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1. Introduction
Mitochondria are thought to be evolved from primeval prokaryotes after symbiosis in
anearobic cells, and they have their own circular DNAs (mtDNAs) and transcription/transla‐
tion systems [1-3]. However, most of the genes (99%) that encode mitochondrial proteins and
components of protein complexes are contained in nuclear genomes [3]. Previous researches
revealed that mitochondria play important roles in the regulation of vital biological events,
namely production of energy [4]. More importantly, recent studies showed that mitochondria
exert signals to affect cell death [5], cellular senescence [6], and DNA repair systems [7]. These
observations imply that mitochondria and nuclei are communicating each other to protect
nuclear DNAs that encode 99% of mitochondrial proteins [8]. Furthermore, mitochondria also
play roles in the responses to various stresses, including immunological reaction [9, 10].
Previously, we surveyed the human genomic DNA data-base and found that promoter regions
of several DNA-repair-associated genes, including ATM, BRCA1, FANCD2, PARG, and TP53,
which encode proteins that regulate mitochondrial functions, contain duplicated GGAA-
motifs [11]. Moreover, numbers of DNA repair and mitochondrial function-associated genes
are linked with partner genes by bidirectional promoter regions containing duplicated GGAA
motifs [12]. These observations suggest that expression of the DNA repair and mitochondrial
function associated factor-encoding genes are commonly regulated by GGAA-motif binding
transcription factors (TFs).
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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and reproduction in any medium, provided the original work is properly cited.
In this chapter, we will focus on and discuss transcriptional mechanisms that regulate both
DNA repair and mitochondrial functions. Not only DNA repair systems, but also several
metabolic enzyme reactions that depend on an inner cellular NAD+/NADH ratio, including
TCA (Citrate/Krebs) cycle and poly (ADP-ribosyl)ation, are thought to be dys-regulated in
cancer or tumor cells. We therefore, propose a novel cancer therapy by introducing GGAA-
motif binding TFs or their expression vectors, activating both DNA repair and mitochondrial
functions.
2. Relationships between DNA-repair, mitochondrial functions and
Immune responses
Telomeres are the specific region of chromosomes that regulate cellular senescence and
chromosomal integrity [13]. It has also been indicated that mitochondrial function is regulated
by telomeres [6]. Several nuclear DNA-repair factors are suggested to play roles in the
maintenance of mitochondrial DNAs (mtDNAs), and damaged mtDNAs in turn exert signals
to regulate nuclear transcription [7]. Some of the DNA repair factors have been shown to
localize in mitochondria. Furthermore, immune system has been suggested to be under the
regulation of DNA repair [14]. Therefore, understanding the co-operation of the telomere-
mitochondria-DNA repair-immune response might contribute to reveal molecular mechanism
of cellular senescence, cancer and immunological diseases.
2.1. Characterization of the promoter regions of genes encoding enzymes that regulate
human poly(ADP-ribose) metabolism
We have found duplicated GGAA-motifs in the bidirectional promoter of the human PARG
and TIM23B genes that encode a poly(ADP-ribose) degrading enzyme and a mitochondrial
inner membrane translocase 23B, respectively [11, 15, 16]. Isoforms of the PARG protein
localize in the mitochondria [17]. PARP1 enzyme synthesizes poly(ADP-ribose)s on various
target proteins, including p53 [18, 19] and PARP1 itself to regulate DNA-repair synthesis [20].
Interestingly, duplicated GGAA motifs are also contained in the promoter region of the human
PARP1 gene [21, 22]. PARP1 and PARP2 enzymes influence mitochondrial function and
oxidative metabolism [23]. It has been shown that PARP1 protein localizes in mitochondria to
maintain mitochondrial DNA integrity [24]. These observations imply that several DNA-repair
factors localize in mitochondria, and that their gene expression may be partly controlled by
the GGAA-motif binding protein factors.
2.2. DNA-repair factors and mitochondrial functions
It is widely known that damage on DNAs activates p53, which is transcribed from the TP53
gene, allowing it to bind to 5’-regulatory elements and activate genes encoding cell cycle
regulators, apoptosis- and autophagy-inducers [25, 26]. The p53 protein does not only act as
a “guardian of the genome”, but also serves as a metabolism regulator [27, 28]. Moreover, p53
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has been reported to accumulate in mitochondria in response to stress [26]. One recent study
revealed that mitochondrial disulfide relay causes translocation of p53 into mitochondria to
facilitate its function for repairing oxidative damage to mitochondrial DNA [29]. However,
overexpression of p53 in mitochondria would lead to depleted mitochondrial DNA abundance
and a reduction in oxidative stress [30]. Oncogenic RAS-induced mitochondrial dysfunction,
which causes oncogene induced senescence, is dependent on either p53 or RB [31]. As a tumor
suppressor protein, RB plays a role in linking cell cycle exit with mitochondrial biogenesis [32].
RB is widely known to control cell cycle progression, maintenance of genome stability and
apoptosis by interacting with the E2F family of TFs [33]. Recently, it was reported that mutation
of E2F1 leads to mitochondrial defects in human cells [34].
Besides p53 and Rb, various DNA repair factors have been reported to localize in mitochondria
or regulate their biological functions. For example, mutations of the BRCA1 gene have become
one of the hallmarks for diagnosis of breast cancer [35, 36]. BRCA1 protein, which plays a part
in the repair synthesis of double-strand DNA breaks [37], is also involved in the mitochondrial
genome maintenance to be trans-located into mitochondria especially when it is phosphory‐
lated [38]. Deficiency of BRCA1, which interacts with FANCD2 protein, leads to phenotypes
that resemble to Fanconi amaemia (FA) [39]. A number of additional DNA repair factors
associate with FA proteins [40]. Recent study of transcripts from bone marrow cells revealed
that FA patients have deficiencies in mitochondrial, redox and DNA repair pathways [41, 42].
Another DNA-repair deficient disease is Ataxia Telangiectasia (AT) that is caused by muta‐
tions on the ATM gene [43]. Recently, it was reported that lack of ATM causes reduced
mitochondrial DNA integrity and mitochondrial dysfunction [44]. Moreover, it was suggested
that mitochondria are required for the oxidative activation of ATM [45]. The duplicated
GGAA-motifs are present in the 5’-upstream regions of the BRCA1, FANCD2, and ATM, which
have bi-directional partner genes NBR2, CIDECP, and NPAT, respectively [11]. Although
BRCA2, which encodes a tumor suppressor to repair double-strand DNA breaks [46, 47], has
no bi-directional partner gene, the duplication of the GGAA-motif is present near its tran‐
scription start site (TSS) [11].
2.3. Apoptosis is executed by signals from mitochondria
Execution of apoptosis or programmed cell death is mediated by mitochondria in response to
various stresses including DNA-damage and immunological stress signals [48, 49]. Previously,
we reviewed the roles of the ETS family proteins on apoptosis, and found the GGAA-dupli‐
cations in the 5’-regulatory regions of the human PDCD1, DFFA, BCL2, FAS, and FASL genes
[50]. The findings imply that expression of the apoptosis regulating factor-encoding genes is
under the control of the duplicated GGAA-motifs. Previous studies revealed that mitochon‐
drial functions closely associate with apoptosis [5, 48, 51]. For instance, it is one of its charac‐
teristics that cytochrome c is released from mitochondria during induction of DNA-damage
signals, and that apoptosis regulator proteins BAX and BCL2 localize in mitochondria [48].
Our in silico surveillance of the human genomic data base retrieved several interesting
examples of duplicated GGAA-containing bidirectional promoters, including ATG12/AP3S1,
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APOPT1/BAG5, and HTRA2/AUP1 gene pairs [12]. The ATG12 and HTRA2 genes encode an
autophagy protein that takes a part in the quality control after mitochondrial damage [52, 53]
and a serine protease that is localized in mitochondria [54], respectively. Importantly, with
assistance of tumor suppressors, such as p53, RB1 and BRCA1, ATG12 and HTRA2 may
contribute to determine cell fate between DNA-repair and cell death after excess cellular
stresses.
2.4. Identification of duplicated GGAA (TTCC) motifs in the 5’-upstream of the human
genes encoding DNA repair factors and apoptosis regulators
We have reported that duplications of the GGAA-motif are found in the 5’-regulatory regions
of the human TP53 and RB1 genes [11]. Moreover, we have found the DNA sequence 5’-
CAATAGGAACCGCCGCCGTTGTTCCCGTC-3’ near the TSS of the human E2F1 gene.
These lines of evidences imply that tumors could be generated from mitochondrial dysfunc‐
tions when p53 and RB proteins lose their intrinsic biological functions as tumor suppressors,
and that expression of their encoding genes are under the control of GGAA-motif binding TFs.
We have also identified GGAA-motif duplications in the 5’-upstream of the APEX1 gene,
which has a bidirectional partner gene OSGEP [11]. The APEX1 encodes apurinic/apyrimidinic
endonuclease 1 (APE1) that regulates both base excision repair and mitochondrial DNA-repair
systems [7, 55]. It is noteworthy that APE1 interacts with XRCC1, which is recruited to the
poly(ADP-ribosyl)ated site [56]. APE1 does not only function as a regulator of the base excision
repair system, but also as a redox regulator [57]. The GGAA-duplication is contained in the
regulatory region of the head-head configured ACO2/PHF5A genes [12]. The ACO2 encodes
aconitase that functions in the TCA cycle to produce citrate and isocitrate and also serves as a
mitochondrial redox-sensor [58]. More importantly, a recent study revealed that aconitase and
mitochondrial base excision repair enzyme OGG1 (8-oxoguanine DNA glycosylase) coopera‐
tively preserve mitochondrial DNA integrity [59]. Additionally, it has been shown that
Cockayne syndrome (CS) proteins CSA and CSB, which play roles in nucleotide excision
repair, accumulate in mitochondria upon oxidative stress [60]. A putative ETS1 binding motif
is located, though no obvious duplication of the GGAA-motif is present near TSS of the ERCC8
(CSA) gene. Interestingly, it has a bidirectional partner NDUFAF2 that encodes one of the
components of the NADH dehydrogenase (ubiquinone) [12]. The observation implies that not
only GGAA-motif-duplication, but also another cis-element may take part in supporting
transcription from a bi-directional promoter.
Collectively, our in silico analysis of the 5’-upstream regions of human genes suggested that
transcription of a large numbers of DNA-repair/apoptosis/mitochondrial function associated
genes could be regulated by duplicated GGAA-motif-containing promoters.
2.5. DNA-repair and immune responses
It should be noted that duplicated GGAA (TTCC) motifs are frequently contained in numbers
of 5’-upstream region of the human interferon (IFN) stimulated genes (ISGs) [61]. BRCA1 has
been reported to regulate IFN-gamma signaling by inducing IRF7 gene expression [62].
Advances in DNA Repair132
MRE11, which is a double-stranded DNA break sensor with Rad50, is required for activation
of stimulator of IFN genes, STING [63]. These lines of evidences imply that response to IFN
should be co-regulated in accordance with DNA repair system when damage was introduced
in chromosomal DNAs. Conversely, IFN signaling affects expression of genes encoding DNA
repair factors. Recent studies revealed that immune system is closely associated with DNA-
repair system. It has been reported that transcription of the FANCF gene is up-regulated by
IRF8 during differentiation of myeloid cells [64]. Moreover, IRF1 has been shown to regulate
BRIP1 (FANCJ) gene expression [65]. IL-4 decreases DNA damage in murine and human
glioblastoma cells when PARP-dependent DNA-repair is required [66]. Over expression of the
IFN-related genes are caused by treatment with DNA-damaging agents and following ionizing
radiation [67]. Interestingly, this over expression is enhanced in the BRCA2 knockout cells.
Integration of viruses into chromosomes might be damage on DNAs because exogenous DNAs
will cause disruption of genes or enhancer insertions. Therefore, DNA repair system should
be immediately evoked upon viral infection. Hence, immune sensing is primarily required to
anti-viral immunity. It was indicated that oxidized base 8-hydroxyguanosine (8-OHG)
potentiates cytosolic immune recognition by decreasing its susceptibility to TREX1-mediated
degradation [68]. TREX1, which is also known as DNase III, is a 3’ exonuclease that is thought
to play an important role in HIV-1 DNA sensing and viral immune evasion [69]. Interestingly,
TP53 gene expression is induced by type-I IFN signaling in CD4+ T cells upon infection of
HIV-1 [70]. Importantly, the concept has been postulated that DNA damage response affects
innate immune sensors that drive metabolism, apoptosis, cancer, and aging [14].
Overall, the DNA repair system, including DNA damage sensing, and IFN response are
thought to depend on and regulate each other. Previously, we identified duplicated GGAA
(TTCC) motifs in a number of DNA repair associated genes, including TP53, RB1, and BRCA1
[11]. In order to examine if GGAA (TTCC) duplication is a common feature of the 5’-upstream
region of the DNA repair associated genes, we proceeded to re-survey of the data base of the
human genomic DNA.
3. Comprehensive analysis of the DNA repair-associated gene promoter
regions
First, we retrieved 568 gene IDs from NCBI_GENE data base (http://www.ncbi.nlm.nih.gov/
gene/) with a key word “DNA repair” on July 20, 2014. Then, we accessed to their individual
sequence data and searched GGAA or TTCC motifs within a region between approximately
540 nucleotides upstream and 90 nucleotides downstream from the putative TSSs. At least one
duplicated GGAA (TTCC) motif is contained in the 630 nucleotide region of 358 different genes
(Table 1). Our defined GGAA (TTCC) duplications, with no more than ten nucleotide distance
between GGAA (TTCC) sequence pairs, are not found in the remaining 210 genes (not shown).
These genes, whose putative promoter regions contain duplicated GGAA motifs, could be
classified into several groups according to the biological functions of the encoded proteins.
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Gene-Partner gene Sequence
ABL1 CGGCAGGAAATTTGTTGGAAGATGA, GTGACTTCCACAGGAAAAGTT
ACTL6A CTACCTTCCCCTACCCGGGTTCCCGCCG, GCTTCTTCCAGCCTTCCTCCTT,TCGCTTTCCTCTTTCCCGCCC
ADH5-LOC100506113 TGAAATTCCCGTTCCCTCACC, CACGGGGAAGCCCTTTCCCGACA
ADPRHL2(ARH3)-TEKT2 GATGGGGAACACTATTCCTCCGA, CGGACGGAAGTAGGGAAACTGT
AKAP9 GAGTGGGAACCAGTGGAGGGAAGAGGG, CCACCGGAACTTTTCCGTTGG
ALKBH1-SLIRP GCCCCGGAAAAAATTTCCGGATCCGGAACACGA, CTTTCGGAAACTTTTCCGCTTC
ALKBH4-LRWD1 CGACCGGAAGGAAGCGGAACCCAG
ALKBH6-LOC101927572 AGACGGGAAAGGAAGTGCTTCCTTCAG
ALPK2 AGTTTTTCCTTTCCTAAGG,TCTTCTTCCAGAACTTCCCCGGGCATGGAATTTCCCCTCTTAGGAAGAGAT
ANKRD26 GACATGGAAGGGGAATAAAC, AGATTGGAAACCGCGGAGTTTCCTTTGG
APC AGGATTTCCCGGAAGAGGT
APEX1-OSGEP CAGCTTTCCGGAGCGCAGAGGAAGCTGG,CACTGGGAAAGACACCGCGGAACTCCC, CCGTTTTCCTATCTCTTTCCCGTGG
APITD1 CGCAGTTCCTGTTCCACTCG
APOBEC3B CACACTTCCTTCCCCACT,GGAGGTTCCTCTGCCAGCGGGAAGGGTCCGGGGAAAACCA
APOBEC3G AAGCAGGAAGGAAAGAGC
AR AGGTATTCCTATCGTCCTTTTCCTCCCTC,GGGAGGGAAAAGGAGGTGGGAAGGCAAG
ASCC3 TAATAGGAATTATTTCCTCCAC
ASF1A AAAGTTTCCGAGTCCATTCCGGGAG
ASTE1-NEK11 ATCACGGAACTGTACTTCCCAGAG, GAGACTTCCGATTCCCGCTC
ATF2 TGCTGGGAAGTGACGGAAACGGA
ATF3 TACTAGGAAAGGAATCTGT
ATF4 TCGCCGGAAAACGACCTTTCCCCGCC
ATM-NPAT AAAGCTTCCCTACCAAGGGAAAACCT, CAGCAGGAACCACAATAAGGAACAAGA,CCTTCGGAACTGTCGTCACTTCCGTCCT
ATR CGGTGGGAACGTGAGGAACTTTT, ACGGCTTCCCGGCTTCCCCCGG
ATRIP CATCATTCCTCCTTGGACTTTCCTCCTC
ATRX TTGGTTTCCTCATCTGGAAAATGT
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Gene-Partner gene Sequence
AURKB CTGGGGGAATTTGGGGAAACTTTCCTAAACTGGAAGCCAA,TCTCATTCCGCCTCTTCCATTGGGTTCCCATGA
BACH2 TGCCCTTCCGGGAAAACGC
BARD1-LOC101928103 GCAGCTTCCCTGTGGTTTCCCGAGGCTTCCTTGCTTCCCGCTC
BCCIP-UROS CTACGGGAAGGGGAGGGGAAGCTTT, GAGGGTGGAAAGCGGAAGAAAA,GCCGTGGAAAGTGGGGTTCCGCAGC, GACGAGGAAGAGGAAAAAGA
BCL2 TTTTAGGAAAAGAGGGAAAAAAT
BCR-BCRP8 AAGTGTTCCTGTTCCAGGAC
BLM
CCGGGTTCCAGCTGCCTACTTCCTTTAA,
TCGGCTTCCCCAGGAAGCAGCCAATCGGAATAGGCAAGCTTCCGGCGGGAAGTG
AG
BRCA1-NBR2 ATGCTGGAAATAATTATTTCCCTCCA, AATTCTTCCTCTTCCGTCTCTTTCCTTTTA,TTGGTTTCCGTGGCAACGGAAAAGCGCGGGAATTACA
BRCA2(FANCD1) GACAAGGAATTTCCTTTCG
BRE-RBKS TCTTCTTCCTGGAATAGTC, GCTGAGGAAGGAACTGTC
BRIP1 (FANCJ) GATACTTCCTTTCCGCTGG, GAGACTTCCAGTTTCCAAGGAATTTGC
BTG2-LINC01136 CCACGGGAAGGGAACCGAC
C17orf70 CCCGCTTCCCCACCCTGGGGAACCCGT
C19orf60 CTTGGTTCCCCTTTCTTCCTTCTG
CAGE1-RIOK1 GCGATGGAAAGGAACGGCT
CCNF GCGGCGGAAGGGAAGGCCG
CCNO CTGGCGGAAGGAAGGGCA
CDC20 CAAGCTTCCCAATTCCGTCCC, TCTCCTTCCCCTTCTAGGAACGGCT,AGACTTTCCCCGGAAGGCCC
CDC25 GCCTCTTCCCACTAGGTTCCATCAT, GGAGGGGAAAGAGGGAAGGAGG
CDK1 TTTTTGGAATCTGGAATATTAGGAATCAAC
CDK2-PMEL CGAGATTCCCGGCTTCCTGGTTTCCAAAGG, GCCAGGGAAACGCGGGAAGCAGG
CDK5-SLC4A2 CCCATTTCCGCTGCATTCTGGAACGCGT,AAACTGGAAAAGATTGGGGAAGGTAATGGAATCTCG
CDK5RAP2 GGTTAGGAACTTTGAGGATTCCTGAGT,CTCGTTTCCGTAGGAAGAAGCGCCGGGAAAGATG
CDK6-LOC101927497 TGTGTTTCCTTGGAATCGGC
CDKN1A(p21) CATTGTTCCCAGCACTTCCTCTCCCTTCCTAGGC, CCTGCTTCCCAGGAACATGC
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Gene-Partner gene Sequence
CDKN2A(p16)-
CDKN2AAS1 AGCCAGGAATAAAATAAGGGGAATAGGG
CEP63-ANAPC13 AAGCGGGAAAGCCTTGTTCCTTGCT, CGATGGGAATAGGGGGAAGTCCG,TCGCTTTCCTCGGATTCCCGGAT
CFL1 GAGATTTCCTTGTACCTTTCCCCTGTGCCTTTTCCTCCTA,AGCGGTTCCTGGGAAATTGG
CHAF1A TGGGAGGAATGGAAGTCAC
CHAF1B ATAAATTCCGGCCGGGATTCCGACCC
CHD1L-PRKAB2 GTGGGTTCCTTATAGGGAATAAGA
CHEK1 TTTTTTTCCTACGGAATCATG, TCGCCTTCCCAAAGTGCTGGAATTACA,CTTATTTCCATTTTTCCTATTT
CINP-TECPR2 ATCGGTTCCTTTCCCGGGG
CLOCK CGGCAGGAAGCTCTTCTTCCTCCTC
CLSPN CCACGGGAACCTTGGAATTCCTCTAA,GCCCAGGAACCGTTTCCCAGCTCACTTCCCCCCG
CLU CTGATTTCCTAACTGGGAAGGCTC, GGCTCTTCCCTACTGGAAGCGCC
COCH AAGTAGGAACTCTTTCCACGAG
COL6A6 GTCCGTTCCACGGTTCCGAGGT, TGCATGGAAGTTTCCCCAAG
COPS5 CCTTCTTCCGGTGCGGAAGACTA
CPT2
GAGTTGGAAGGAATCTTG, TGACAGGAAGCCTCTTCCAATAG,
AACACGGAAGACTTCCTAGAG, GGGGATTCCGCTCGGAAGGGGC,
CAGCGGGAAACTCCAGGTTTCCAACTC
CRY1 AAAAATTCCAGGAAGTCCAGGAATGCCT,CTGAAGGAAACCGGACAATTTCCAGGCC
CSNK1D CGCGAGGAACTCACCTGGCTTCCTCGAC
CSNK1E TCCCAGGAACTGTGCTTCCGGGAT
CUL4A ATCCATTCCCTATATTTCCTATCC
DCK ACTCCGGAACCTCTTCCCGCGC
DCLRE1A-NHLRC2 CAGCGGGAACTTGTTCCCGCCA
DCLRE1B TCCAGTTCCAGCCTTAATTCCCCCTC
DCLRE1C-MEIG1 TAAACGGAAGAGGGAATTAATAGTTCCTGAAT, AAGCAGGAAGCGGAACGAAG,TCGATTTCCCTTCCCGCGA
DDB1-DAK AGTCCTTCCCGTTCCCAAAGGAGGAACAGCCC
Advances in DNA Repair136
Gene-Partner gene Sequence
DDX1 GAGGATTCCTCATTTACTTTCCCCATC
DDX11-DDX11AS1 GAGCGGGAAAACATTCCGGAAGTGGA
DEK ATCTTTTCCAGGAAGCGACCGTGGAAACAAT, CGTCCTTCCGTTCCGCGCT,CCGCATTCCCGCTCTCCTTCCCGAAC
DHFR-MSH3 GGCTCTTCCCACCTTCCCCTTC
DNTT GATCTGGAAAACATAGTTCCAAGTG, GATGCTTCCCTACCTTCCTCACG
EGF GGGATTTCCCTTTGATTTGGAAAGAAT, CCTGCTTTCCTGTGTGGAGGAATTGCC,TAGCTGGAACTTTCCATCAGTTCTTCCTTTCTTTTTCCTCTCT
EGFR AGAAGGGAAAGGGGGAAGGGGA, TGCTGGGAACGCCCCTCTCGGAAATTAA
EGR1 AGGGCTTCCTGCTTCCCATAT
EIF2AK3 TTGTAGGAAAGGTATTCCGGGAACTGAT,CACCAGGGAAAGTCCACCTTCCCCAAC
EIF3A GCTCCTTCCTTTCCGTCTC
EME2-MRPL34 CGGCCGGAAGTCACCGGAAGAGGC, CGGCCGGAAGCGAGGAAGAGGT
ENDOV-LOC100294362 GGGTGGGAAGTGCGGCCCGGGAAAGCGC,GTCGCTTCCGGAAGTGACGTGCGGAAGGGGT, CCAGTTTCCGGCGCGGAAGCGGA
ENG TCTAAGGAAGCGCATTTCCTGCCT
EPC1 TTTTTTTCCCAAGGAATTAAA
EPC2 GGAGGGGAAGGGAGAGGAAGGAGG
ERBB2-PGAP3 GAAGCTTCCACTTCCGGAGTAACCGGAAGTTCCTGTGT
ERCC1 AATTCGGAATTTTCCGAGAA
ERCC2(XPD) GCTCTTTCCCTTCCATGTT
ERCC3(XPB) GGAGCTTCCGGATTGAGCCGGAAGTCCC
ERCC4(FANCQ) CTTACTTCCCCTTCCCTTGC
ERCC6L2-LINC00476 CAGAGGGAAGAGACATCGGGAAGATTG
ERN1 GTTCATTCCAAGCGGAAGTGAT,TGAGGGGAATTCCTGAGGGCAAGGAAAAGGAAGAAAG
EWSR1-RHBDD3 CGGACGGAACCATTCCAAACA
EYA1 CTTTTGGAAGAACCGGTTCCTCAGC
EYA3 ATGTCTTCCAAAACTTCCCACTC, CTTACTTCCGGTTCCTAGCG
EYA4
GAGAGTTCCAG
GCAATTCCGGGGG, GGCCGTTCCCGGCTTCCGCGCAA
AACTTCCATCCT, GAGGGGGAAAGAGCTGCGGGAAAAGCC
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Gene-Partner gene Sequence
FANCA AGTCTGGAATTCCTGGGC, AGTCATTCCCGGCAGGAACCACG
FANCB-MOSPD2 GAGTCTTCCCTTCCCAGGA, GAGAGGGAAGGAAGCGGG
FANCC TCGTCGGAATTTTCCCGCGA, CCGCGGGAAAATTCCAAAAA
FANCD2-CIDECP CGGCCTTCCACTTCCGGCGCGGAAGTTGG
FANCE CCTCCTTCCCTTTCCGACAGCGCGGGAACGGCT
FANCF GATATTTCCAAAGCGAAAGGAAGCGCG, CGTGGTTCCGGAAATTCT
FANCG TCGGTGGAAGCGGGAACCCAG
FANCI CTGCCTTCCAGGCTTTTCCAGTGC
FANCL TTCATTTCCGCCCGCGGAATCCTC
FANCM TCATTGGAAACGGAACTTAA, AATCATTCCCAACGGAAACTCA
FBXO6 CATAAGGAAGGAACTAGT
FEN1-TMEM258 GGGGCTTCCCCCTTCCCCACC, CAACCGGAAAAGGAAGTGCC
FGF10 AATTCGGAAAGCGGGAAGATAC
FNDC4 GAGGTGGAATTCCTCTTCCCAACT, GGCTCTTCCACGCGGGGAGGAAGGGGA
FOXM1 ACGATTTCCCCCAGTGAGGAAATCAA
FOXO3 CTCGTGGAAGGGAGGAGGAGGAATGTGGAAGGTGG
FUS CCACAGGAATCTCGGTTCCACCCC
GLB1 TGCAGTTCCAAAGGGTCCCTTCCCAGGGAAGACGC
GSTP1 GCAATTTCCTTTCCTCTAA, CTTAGGGAATTTCCCCCCG,ACCTGGGAAAGAGGGAAAGGCTTCCCCGGC
GTF2H1-HPS5 TCGCGTTCCTCCCCTTCCTTGCT, GGGAGGGAACTAGCGGAAGGTGT
GTF2H2 GTGAATTCCAGCTGGAACACCGTCCCTTTCCGCGCC,GCGGCGGAATGACTTCCGGGGC
GTF2H3-EIF2B1 CCCACTTCCGGCGCACTTCCGTACCCCTCTTCCGGCGC
GZMA AGTGGGGAAGGAAAATCC
H2AFX TGGTCTTCCGCTTCTGGTTTCCGATTG
HERC2 GGTGTTTCCTTCTTCGATTCCCTGCA, GTGGCGGAAATCCCGCCTTCCGGCGC
HELQ-MRPS18C CATGGTTCCGCGTTTCTTCCACTTCCTTTCGTTCCAAATCGTTCCGAAAGGCCCCTTCCGCTGCTCTTCCCCTGT
HINFP CACTGTTCCCGCCCCTTCCGTGTT
HLTF-HLTFAS1 ATAAAGGAAGGTCGTTTCCCTCCG
Advances in DNA Repair138
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HMGB2 GGGCTTTCCTTCCCGAGC
HNRNPC CAATAGGAAGATTCTCAGGAATGGGG
HSPA1A-HSPA1L ACCCTGGAATATTCCCGACC
HSD17B6-PRIM1 CCACAGGAATTGGCGGGAACAGCA, CGCCGGGAATTGTAGTTCCCACTT,GTCCATTCCAGGAAGAGGA
HTATIP2 AGAAAGGAATCAAAGGAATCCTG, GTGAGGGAAAACGCGGGAAGAGGG,GCAGATTCCAAACTTAGGAAGGGTC
HUS1B GGAGTGGAAACGGAAGCATT
HUWE1 TCATGTTCCCTTCCGCGGCTTCCACCGT
IER3 TCGTCGGAATTTCCAGCCC
IGF1 AAATGTTCCCCCAGCTGTTTCCTGTCT
IGF1R TGAGCGGAAAAAAAAAGGGAAAAAAC
IGFBP3 GCCGCTTCCTGCCTGGATTCCACAGC
IGHMBP2-MRPL21 CGGCCGGAAACGGAAACGAC
IL18 TGGGAGGAAGGGGAAGTCCT, TCGACTTCCATTGCCCTAGGAAAGAGC
INO80B GGACCGGAACGTTCGTTGGAAGGATC, AGTTTTTCCGCGGGGCGGAAAAGGC
INO80C ACCTTTTCCGCGTGGGAAGGCAG
INO80E-HIRIP3 AGTCAGGAACGGCGCTTTCCAGCGT,ATACCGGAATCTGAAGCGGAAGCTCAAGTTCCTCATC
IPO4 GGGCATTCCTTCCCCAGA, GCCCTTTCCTCCGGAAGTGGG
IPPK AGGCCGGAAGCTTCTCTTCCGGCTC, CCGCGTTCCGGAAATGAG
IRS1 TAAATTTCCTGGGGGAAACAGC
JMY GGGCTTTCCTCAGACACCTTCCTTTCA,CTCAGTTCCTCCGCCTTAGTTCCTCTTTTCCCGGGT, TGCGCGGAAGGAAGGAGA
KAT5 AGCTAGGAATCTTCCCTGAG
KDM4A GCAGCTTCCCTTCCCTGTT
KIAA0101-TRIP4 CCATCTTCCCCAGCCGGAACCAGC,
KIF2C GAAGTTTCCCAGTTTTCGGGAACCCCG, GCGTAGGAAGATGGTTGGGAACTGCG
KIF13B TGGCAGGAAATGAGCAGGAAGAGGT
KIF22 GACTGGGAACCGGAACCGTG
KIN-ATP5C1 CCCGGTTCCGTTTCCGGCTG
KLF8 CTCCGTTCCTTTTAGCTTCCTCCCT
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Gene-Partner gene Sequence
KRAS CCCTCTTCCCTCTTCCCACAC
LCT ACATTTTCCGGGTTCCTCTGC
LMNA-MEX3A TTTCTTTCCATTATTCCAGATA, GTGGTGGAAGGGAAAAGAG
LIG1-C19orf68 GGCGCTTCCACCGATTCCTCCTCTTTCCCTGCC
LRRCC1 AATGTTTCCAGGAACAAGA, TTTTCTTCCTCATACAGGGAAGTGAC,AGGCGGGAAAGTTCCCGGCT
MAD2L1 TCTCGGGAAAAGCTGCGTTCCCACAC
MAD2L2-DRAXIN GGACTGGAAGGAAGGGGG
MCM8-TRMT6 GCCGCTTCCGCTTTCCGGCCC, ACCGCTTCCGGAAGCCTCTCGGCTTCCGTCTG,CTTCTGGAAGCTGCGGTGGGGAAACTGAGTTTCCCGAGC
MCRS1 TCGTGGGAATTTGGAAGTCGA, AACTAGGAAAGCCTTTACTTTCCGCTAT
MDC1 ACGTATTCCCAGGAAGAAAG, CAAAAGGAAATGAAATTCCAATGC
MGRN1 CGCTTGGAACGCAGAGGGAAGGACC, GTTGGTTCCTTCCCTCTG,TCCTGGGAAAGATAGTTCCCAGACGGGCTTCCCGCGCTGCTTCCCGGCG
MIR96 ACGTCGGAAACAGGCTGCTTCCAAGGG
MMS22L GTGCTTTCCAAGTTTTCCATATC
MNAT1 TCATGGGAATGTTTCCAGACA, AAGATGGAATTTATCTTCCTAATT,CCGGGGGAACTGACTGCCGGAACGTTT
MORF4L2 ATTTTTTCCTAGGAATGAAC
MPG GGCTGTTCCCACAGGAAGGAGA
MPLKIP-SUGCT GTAGCGGAAGCAGCTTCCGGGGAACCCCG
MRE11A-ANKRD49 GCAGGTTCCCAGGCGGAAGCCCA
MSH3-DHFR GATTCTTCCAGTCTACGGGAAGCCTG
MSH6 CGCTGTTCCCGCTTCCGCTCC
MSL1 CCGCTTTCCCCTTCTTCCCGCGG
MYB GTGCGGGAATTTCCCCCCA
MYO5A CCCTAGGAATGCTTGGAAGGACG
NABP2-RNF41 TCCCGGGAAGGGAAGGGAAAGGGGAAGGAGGGGAAAGAAG
NBN(NBS1) GGTTGGGAAGCTACTGGAATTAGG, CAGGTGGAAGTGGAAAGGAAGGGTA,CTAGATTCCAAAGGAATACCT, TGCTGTTCCTTTTCCAACCA
NCOR2 GGCGCTTCCCCCCTCCTTCCTCCTC
NDNL2 TGCACGGAAAACGCTGTTCCTTTTGG
NEIL1 GGCGGTTCCTTCCGCCGG
Advances in DNA Repair140
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NEIL2 CCACTTTCCAGGGAATGAGC
NES CCTGGGGAAGCAGGAACAGAG
NFRKB(INO80G) GGACGGGAAGGAGGAATGAAGGAACTCGGAAGCACA
NIPBL-LOC646719 GTGGCGGAAGTGGAGTGGGGAAGAGGG
NLRP11-NLRP4 CGGCTGGAAGCGGGAAGAAAA, GGAGGTTCCTATTGAGAATTCCCAGGG
NONO TCCCCTTCCTCTCCCTCTTTCCACTTTCCTCTCC
NPAS2 GCAGATTCCTTGTTCCCCCCG
NPM1 CATCTTTCCTTCCTAACA
NR2C2 CGCTGGGAAGAGGAAGAAGA
NSMCE1 CTCAGTTCCACAGATGGGGAAACTGA, CAAGTGGAAGCCCCTTCCCATTA
NSMCE4A CGAACTTCCGCCGTTCCGAAGT
NUDT1-FTSJ2 CCCGGGGAACTGCGACCCGGAATCCTG
NUPR1 ATCCCTTCCCCCTCCTTCCTCACG
OFD1 TAAATGGAATCACTAATGAGGAAAGGCA
OTUB2 TACCCTTCCTGGATTCCAGAAA
PALB2(FANCN)-DCTN5 AGAGATTCCGGCTACTTCCGGCCG
PARG-TIMM23B GCCGCTTCCCCCGCCTCCTTCCATGGT, TGACATTCCGGGCGCCGGTTCCCGTTA,GCCCCGGAAGCCGGAAGCGCC, CAGCTTTCCGGTGGTGGGAAAGTGA
PARP1 GCGGGTTCCGTGGGCGTTCCCGCGG
PARP2-RPPH1 CCCCCTTCCCCTTCCAGCTC
PARP4 CCTGTTTCCACGAACTTTCCCGAAA, CCCGATTCCGGGCGCGTTCCGGCTA
PARPBP-NUP37 AAGTGGGAAGGAAGAACTCCTGGGAATAGAG
PDE4DIP TCAAGGGAAAATTGAAAGGAAAAGATTTTAGGAAAGAGA,
PIWIL2-LOC100507071 CACAGGGAACCTGCTGGAAAGGAC
PMS2-AIMP2 TGGAGGGAACTTTCCCAGTC,CGGCATTCCAACCTCCCTGGAAATGGGGGGAACATGG
PNKP AGATGGGAAAAAAATCTTCCTCCCT, GTCATTTCCGTCCGCCGAGGAACCGAC
POLA1 TCGCTTTCCCGGCTCTGGGGAAAACGA, CTCCTTTCCGGGAAAATGG,TGGCCTTCCGGCCGGAAGTCCG
POLB CCCGTTTCCCCTTCTAGGGAAAGGATTCCAGATA,AGGTCTTCCCATAGGAAGGCCC
POLD1 GGCGGGGAACAGCGGAAGTGAG
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Gene-Partner gene Sequence
POLD3 CCTCTGGAAAAACCTTCCCTAAT
POLD4 GCCTAGGAAGGGAAAACGGGAAGTGAG
POLG CTTCGTTCCTGAGGGAGGAATAAAC
POLH-XPO5 AGCCCTTCCATTTTCCTTCCAGTAG
POLI CAGGCGGAAGCGGCCGGAAGTAGC
POLL AACCGTTCCAGAGGGTCACTTCCGGCTGACTCGGAAGCTAT
POLM GGGGCTTCCTTCCGTCTC
POLQ CCCAATTCCTCATTACATATTCCTCACA
POLR2A-ZBTB4
GGGCGGGAAAGGAAGGGGC, ACCTTTTCCTTTTCCCTTCT,
AAAATTTCCGGTAAGGGAAAGAAG,
CTTATTTCCCCGCCTCCTTCCCTCCCCCACCTTCCCCTCC
POLR2B TTCTGGGAACGTCGGAGACGGAAGTTAC
POLR2F-C22orf23 CTCCCGGAAGTGATTTCCTCTGG, GCCGAGGAAGGGAAGGGCG
POLR2G AGTGTTTCCGGTGGATTCCCAGGG
POLR2I CCCCCTTCCGGGAACCCCC, GTCCCTTCCCCACCGCCAGGAAGAGGG
PPM1D CCTTTGGAAGGGAGGTTTCCCGCCA
PPP1R15A CTTACTTCCACTTCCCACCC
PPP5C AGAGAGGAAGGGAAGATTT
PRKDC(DNA-PKCS)-
MCM4
ATCGAGGAACAAACTTGGAACTCTT, CGTTTTTCCTTAGGTTTCCATGTT,
CCCCGGGAAAGTTCCTGCCG
PRMT8 GGCATGGAAAACCAGGAAGTTTC
PRPF19 TTCTGGGAAAGGGCAATTTCCGTTAG
RAD1-BRIX1 TTCACTTCCTCCGCGGTTCCTCGGA
RAD9B-VPS29
GTTTATTCCCTTTCCCTAGA,
TTGCGGGAAACGAGTAGGAACCGTCTGGAAACGGA, CTCCCTTCCTTCCCTAGA,
GGGATTTCCCAATTCCTCGCC
RAD17 CCAACGGAATTAACGTTCCGCGTC
RAD23A AACCCGGAAGGCGGAAGCTGC
RAD23B CGACATTCCAGGACCGCCTTCCGCCCC
RAD51AP1-C12orf4 TGGGAGGAAAACTAAGGGAAAAGAC
RAD51B AAAATTTCCAAACAGGGTGTTCCCTTGT, GCGTTTTCCGCGGGGAAACTGT
RAD51C(FANCO)-TEX14 TTTGGGGAATCAAAACGGAATGGTG
RAD51D ATCCGTTCCGTTTGGAACGGAAGCTGG, AGCCTGGAACCCGGAAGCGGC
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RAD52-ERC1 GGTGAGGAACTGGGAAGCGGG, CCGTAGGAAGTGGACGCTGGAAGCCCG
RAD54L AAATCTTCCCTTCCATAGC, CACTATTCCCGCCTCTTCCTTGGG
RAF1 ATGGGGGAAAAATGAACTCGGAATTTAC
RASSF CACTGGGAAAAGCATGGAAAGACT, AGGAGGGAAGGAAGGGCAA
RB1-LINC00441 CAGGTTTCCCAGTTTAATTCCTCATG, CGGGCGGAAGTGACGTTTTCCCGCGG
RBBP8 TTTGATTCCATGTTCCACAGA
RBP14 CCCAGGGAATGTTTCCAAAGA
RECQL-GOLT1B ACGTCTTCCGGAAACACG
RECQL5-SAP30BP CCCGATTCCCCCTTCCAGCTT, CCGACTTCCGGGCGGAAAGGCA,AACAGTTCCGGAACCAGC
REV3L-TRAF3IP2 GTTCGGGAAGGGGGAACGCCA
REXO2 ACTCAGGAAATAACTCCTGGAAGCAAA
RFC2 GGGGTGGAATTCCCATCT
RFC5 AGGGAGGAAGTCGGAAACTGG
RHBDL2 GCCCAGGAAGCCTGGAACGCAA
RIF1 GGCAGGGAAGGGATGGGAAGGGATGGGAAGGGAG
RMI2 CCCATTTCCTCCGTTCATTCCTAACT
RNF2 AGAGTGGAAGGTCATTTTCCCAGGA
RNF4 CGGCTGGAAATCTAGGAATGGGAAGGTTC
RNF44 GTAAGGGAAGGCCCTCACTTTCCCCATC, CTTAGTTCCCAGTTTCCCTGGC,ACCTGTTCCCCGCCTCTCTTCCTCCAC
RNF113A GCTCCGGAAGAAGCGACGGAATCTGC
ROCK1 GCTTCGGAACTTTCCCAGTG, GCTGGTTCCCCTTCCGAGCG
RPA2 TTTGAGGAAGGAACTGAC
RPA3 TTTTCTTCCTCTTTGGAATTAAA
RPS3 CCCCTTTCCTGTTCCTGCCT, GCCACTTCCTTTCCTTTCA
RPM1 TTTTCTTCCAGTTCCAGAGT
RRM2B CCAGCGGAAGCAGGGAGATTTCCTTAGG
RTEL1 AAGCTGGAACGCAGGAGAGGAAGGAGA
RUNX1 ATTCTTTCCCTTTCCCAGGC, TGGAGGGAAGGAAGGGCA,GCTGTGGAAAGGGGAACAGTT
RUVBL1-EEFSEC ACCCGTTCCGGCCCGGAAGCTTCCGCCCT
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Gene-Partner gene Sequence
SAMHD1 CCACTTTCCTTCCTCTGGGAATGCAG, AATCATTCCGGGTTCTTCCAGTTC,CTGTTTTCCTCTTCACTGGGAAGGTGC, GCTCTTTCCTCCCCCTTTCCACCAG
SAT1 CCTCTGGAAAATTCCATTGT
SERPINE1 CTGGGGGAAAACTTCCACGTT
SETMAR GTCAAGGAAGGGAAGCGCCTTCCAGGCC
SETX GGCCTTTCCCGCAGTGTTCCCCTGG
SF3B3-COG4 CGTGTGGAAGCAAGACGGAAGCATT
SFPQ CTGTATTCCTATGAGGTTCCATAAT
SFR1 CGAGAGGAAACTGGATTTCCAGTTT, CTCTCTTCCCCTTTGTAAATTCCTTGGG
SIRT1 CTTCAGGAAGACGTGGAAATTCCCAGGG
SLC30A9 CATCCTTCCCATCTTTCCTCCCATTTCCGAAAC, CCCCGGGAAGGAAGGCCT
SLX1A-BOLA2B GCCACTTCCGCTGGAAAACTCACTTCCGCCCT,GCGGCGGAACTCAGGGAAGGAGC
SLX4 (FANCP) GCAGAGGAAGACCGGAAGCGAG
SMAD3 CGTGTTTCCCAGGACTTCCTCCCC, GGACTTTCCTTCCCGGAG
SMARCB1 AGAGAGGAATGGAGAAGGTGGAAGGTGT
SMC1A-RIBC1 GGTCCTTCCAATTCCCGACC
SMC2 TCAAAGGAATAAATAGTTCCGGCGC
SMC3 CAGCATTCCATGTGTTCCAAGGC, GGCGCGGAACCTTTCCCCCTT
SMC4-IFT80 TCAAGTTCCAGGAAAGCGG, CTCCCTTCCTCTTCCCGCGA
SMC5-SMC5AS1 CGGTGGGAACGGAAGTCGC
SMG1 CTCCCTTCCCTTCCATCGT, GTGCTTTCCGGGAAGCGTT
SMO ACGATTTCCACTCATCTCTTTCCCCCGG
SMUG1 AGCATTTCCGGCGGAAGTGGC, GTGGGGGAAAGGAACCGGAAACGGG
SOX4 TCGGGTTCCAAGCCAATGGGAAGCCCG
SP1 CTGGTTTCCTTCCAAGCC
SPATA22 GATTCTTCCAGGAACAACA, GTCGAGGAATTCCCGGAAACCTC
SPIDR CCCGGGGAAGGAAGCTCG
SPTAN1 CCTCGGGAAAGTGAGCAGGAAGAGAC
SSRP1 ACGCGGGAAAAGCTTCCCCGGT
STAT3 GGACATTCCGGTCATCTTCCCTCCCT
STRA13 CCGGCTTCCGGAAGGTGA
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STUB1 AACTCTTCCCGATACCTGAGGAAGGGCG
SUMO1 CCCATTTCCCGCCTTGTCTTTCCTCTCT
SUPT16H TTGTGGGAAGGAACTAAA, GCTCTTTCCGCTCCCCCTTCCTTTGC
SUZ12 TTTTTTTCCTCCCTCCTTCCCTCCT
SWI5 TCAGTTTCCCAAGACCTGTTCCACAGA, TCCCCTTCCAGCTGGAAATTTA,CTACATTCCACTCCTAGGGGGAACATCA
SYNE2 CAAGGGGAAGGAGGAACCCAG, CCTACTTCCAAGACCCAGGAATCTAC
TCEA1 ACGGGTTCCATTTTTCCCCGTA, CAAAGTTCCATGCTCGGAATCTGC
TDP1-EFCAB11 GGCAAGGAACGTGGGGCGAGTTCCTTTTC (11 nucleotide distance)
TDP2-ACOT13 ACTTCGGAAGAGCTGGAAAGTCC
TDRD3 TTTTGGGAAGACCAAACGGAATACCC, TCCCCTTCCTTCCGTAAC,TACCCTTCCGCCTGTTCCTCTCT
TERT TCCCCTTCCTTTCCGCGGC
TICRR AAGTTTTCCTCGGTCTTGGGAAACGTG, GCTGTTTCCCTGAAGGAAGGGAC
TIRAP CCTTTGGAAAAGTTCCATCTC
TK1 TAAGCTTCCTTCTTGGAATTCCAATCT,TCTTCTTCCAAGGAACCTTGCTTGGGAAACCCA
TONSL CGTACTTCCCGGAATGCCC
TOP2A TCAGTTTCCTCAGGAAAACGA, ACCCCTTCCCGCTTCCAAAGC,ATCTCTTCCAAGCTTTCCGCACG
TOPBP2 ATTGAGGAAATCCTTTCTTTCCCTGGC, GTCACTTCCACCGGAAAAGGC
TP53-WRAP53 TCCATTTCCTTTGCTTCCTCCGG
TP63 ATCAAGGAATTTCCCTGTC
TREX1 GCTTCTTCCAGAGGTTCCCCAAC, GCCGCGGAAACCGATGTGGAAGACCC
TREX2 CTCCCTTCCTTCCCCAGC
TRIM56 CTCCAGGAAGCCTGTGCTGTTCCCTCAG
TRIP12-FBXO36 GAGGGGGAATTAGTTCCTGCTA
TTC5 TTTGTTTCCAGGATCTGGGAAAGAAA
TYMS CCGCAGGAAAACGTGGGAACTGTG, CCAGGTTCCCGGGTTTCCTAAGA,CCGCGGGAAAAGGCGCGCGGAAGGGGT
UBA1 CCCAAGGAAGAATTTCCAGCAC, ACACGTTCCGTTTCCTCTTCCCACCC
UBA2 CGCCCTTCCCCCACCCGCTTCCGGCCG
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Gene-Partner gene Sequence
UBB TGCAAGGAAGTTTCCAGAGC, ATATTTTCCTAAAGAAGGAAGAGAA
UBC-MIR5188 GTACAGGAAGGTGGAAGAACA, GGGGTTTCCGCCTCTTTTTTCCAAATT
UBE2B-CDKL3 CTTCAGGAAGCCCAGGGGGAACCGCG
UBE2T CTAACTTCCACTTGAACATTTCCAGTGATGAAGGAATTCAC,ACGATTTCCAGCTCCTTCCTTGGT
UBE2V1 GCGCCGGAAGGAATCCTG
UBE2V2 ACAAGGGAATTGCGGAAACAGC
UBE2W TGGTTGGAAACGAAATAGGAAAAAAA
UBR5 ATAATTTCCTTACTTTTCCAATAA
UHRF1 AGGCGGGAAAACGAGGCGGGAAAAGAC
UNG GGGCAGGAACTTTTCTTCCCAGCC
UPF1 GATGGGGAAACTGAGTTCCAAGCA
USF1 GAATGGGAATCAAGATTCCTGTCA, CTTCTTTCCTGGAATGAAA
USP1 GCGCGGGAACCCTGGGAAGCTCC
USP3 CACCCTTCCCGGGGCCGGGGAAGCGGC,GACTAGGAAAGTCACTTCGGAACACAG, GGCCTGGAAAGGCGGAAGCCTC
USP28 TGATGGGAAATCCTTTATTCCACGGT, GCAGTTTCCCACGGCGGGGGAACAGTT
USP47-LOC102724878 GAGAAGGAAGTTCCCTGGAAGAGGG
UVSSA AGACCGGAACTTCCTTTCG
VCP GAGAATTCCAATCCGTCGAGGAAGCGTA
VWA2 AAAAAGGAAATGGAAAACCT
WRN AGGTGGGAAGATGGGAATGAGG
WRNIP1-MYLK4 GGGCCGGAAGACGACCCCTTCCTTTCG
XIAP CATCCTTCCCTTCTTGGAAACAGA, CTTTCTTCCACTATTCCTCAAC
XPC-LSM3 CATTTTTCCTGAGTCTGGAAAAAGC, GCTCTTTCCTGCTTCCCGCAG
XRCC1 GCTAAGGAACGCAGCGCTCTTCCCGCTC
XRCC3-ZFYVE21 CGGCGGGAAGAGGAGTGCGGAACCCGC
XRCC4-TMEM167A GTTTTGGAAGATACCGGAAGTAGA
YBX1 CTCGTGGAAGTCACGTTCCTTCTG
ZC3HAV1(PARP13) GCTCTTTCCGGGAATGGGT
ZNF143-LOC644656 CCAATGGAAAACCGGAAGCGTC, ACGAAGGAATTGTTGGAAAATTT
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Gene-Partner gene Sequence
ZNF668-ZNF646
GGGAGGGAAGGGAAAGAGGGAAAGGAG, AGGGGGGAAGAGGAAGGAGG,
TACTAGGAAACAGGAAGTGTC, AAAGCTTCCCCGCGAAACTTCCGCTTC,
TTAAAGGAAATGTTGTGGAATATAA
ZNRD1-ZNRD1AS1 TGGTGGGAAAATTTGCTGGAAGCGCAG, CCCCTGGAAAGGGTTCCAAGTC,GTCTGGGAATTCCGGGCG
Table 1. GGAA motifs located in the 5’-upstream regions of human genes encoding DNA-repair associated factors.
Duplicated GGAA (TTCC) motifs (bold) that are located between 540-bp upstream and 90-bp downstream of the
putative transcription start sites (TSSs) of DNA repair-associated protein encoding genes are shown. Several of them
have bidirectional partner genes. In that case, extra sequences containing both of the most upstream were surveyed.
Nucleotide sequences contained in the 5’-upstream of the partner cDNAs are also included.
3.1. Classification of DNA repair genes whose upstream regions contain duplicated GGAA
motifs
Numbers of genes (Table 1) encode proteins with multiple functions. However, they could be
categorized into several groups as follows:
1. Nucleotide excision repair (NER); ATR, CDKN1A, ERCC1, ERCC2(XPD), ERCC3(XPB),
ERCC4 (XPF), GTF2H1, GTF2H2, GTF2H3, H2AFX, LIG1, PARP1, POLD1, POLD3, POLD4,
RAD23A, RAD23B, RFC2, RFC5, RPA2, RPA3, UVSSA, XPC, XRCC1... NER is a DNA
repair system that is executed with several functional proteins, which recognize a lesion
to form TFIIH complex to excise the lesion introduced DNA chain and the gap is filled by
DNA polymerases [71].
2. Transcription coupled repair (TCR); APEX1, BRCA1, CDK1, CDK2, CDKN1A, CDKN2A,
ERCC1, ERCC2, ERCC3, ERCC4, GSTP1, GTF2H1, GTF2H2, GTF2H3, LIG1, MRE11A, NBN,
PARP1, POLD1, POLD3, POLD4, POLH, POLR2A, POLR2B, POLR2F, POLR2G, POLR2I,
PRKDC, RFC2, RFC5, RPA2, RPA3, SP1, STAT3, TERT, TP53...TCR is thought to regulate
genomic integrity. This process begins with unwinding the double stranded DNA by
TFIIH, the next step is that the damaged strand is incised apart by XPF, XPG and endo‐
nucleases, then gap is filled and finally the nick is ligated [72].
3. Fanconi anemia proteins; ATM, ATR, BRCA2 (FANCD1), BRIP (FANCJ), CHEK1,
ERCC4(FANCQ), FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI,
FANCL, FANCM, NBN, PALB2 (FANCN), LMNA, RAD51C (FANCO),
SLX4(FANCP)...Encoded proteins are involved in Fanconi anemia pathway that plays a
part in the repair of inter strand cross links [73]. Notably, all genes that encode protein
components in the Fanconi anemia core complex are listed in Table 1.
4. Double strand break (DSB) repair, Non homologous end joining (NHEJ); APC, APEX1,
ATM, ATR, BLM, BRCA1, BRCA2, CHEK1, DCLRE1A, DCLRE1B, DCLRE1C, DDX1,
ERCC1, ERCC4, FEN1, LIG1, LMNA, MCM8, MRE11A, NBN, PARP1, RBBP8, POLA1,
POLB, POLH, POLL, POLM, POLR2A, RAD51AP1, RAD51B, RAD51C, RAD51D, RAD52,
RECQL, RECQL5, SP1, TERT, TP53, TREX2, XRCC4... DSBs are caused by stresses on
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chromosomal DNAs, such as irradiation of ultra violet or X-ray, and alkylating agents.
Unrepaired DSBs will lead to collapse of stalled replication forks and in response to
uncapped telomeres [74]. Some of the genes that encode protein components in the MRE11
complex are listed in Table 1. Not only serving as regulator of the mammalian DNA
damage response, the MRE11 complex plays an important role in the maintenance of
telomeres [75].
5. Base excision repair (BER); APC, APEX1, BRCA1, BRCA2, CDKN1A, CHEK1, ERCC1,
ERCC2, FEN1, LIG1, NBN, NEIL1, NEIL2, PARP1, PARP2, POLA1, POLB, POLD1, POLD3,
POLD4, POLG, POLH, POLI, POLL, POLL, POLQ, RAD23B, RECQL5, RPA2, RPA3, RPS3,
TP53, TREX1, UNG, WRN, XPC, XRCC... BER is a fundamental repair system to eliminate
nucleotide-bases from mutated nucleotides that is recognized by AP endonucleases. FEN1
and Ligases fill the gap to ligate DNA ends [76, 77].
6. Apoptosis; ABL1, APC, BARD1, BCL2, BCR, BLM, BRCA1, CNKN1A, CDKN2A, CHEK1,
ERCC1, ERCC2, ERCC3, ERCC4, HMGB2, KRAS, LMNA, MRE11A, PARG, PARP1, PARP4,
RAD23A, RAD23B, RAD51B, SIRT1, SUMO1, TERT, TOP2A, TP53, TP63, XIAP... Apop‐
tosis or programmed cell death is executed by a number of proteins, including mitochon‐
drial protein BCL2 and tumor suppressor p53 [48, 51]. It is thought to be an important
process to eliminate cells with unrepairable DNA damage.
7. Mitochondrial functions; ADPRHL2 (ARH3), APEX1, ATM, BARD1, BCL2, BRCA1, BTG2,
CDKN1A, CDKN2A, ERBB2, FEN1, FOXO3, LMNA, PARG, POLG, SIRT1, STAT3, SUMO1,
TERT, TP53, TP63, XIAP... Mitochondria and nuclei are communicating to regulate each
other [6-9]. Several of the DNA repair factors, including p53 and BRCA1, have been shown
to localize in mitochondria [78, 79]. It has been shown that mitochondrial matrix-associ‐
ated proteins are poly(ADP-ribosyl)ated [80]. Poly(ADP-ribosyl)ation, which is catalyzed
by PARP enzymes, is a modification of proteins utilizing NAD+ molecule as a substrate
[81]. The NAD+/NADH ratio is thought to regulate mitochondrial metabolism. A recent
study showed that decrease in NAD+/NADH ratio, which is thought to occur by an
aberrances in mitochondria, does not only enhance cancer progression but also metastasis
[82].
8. Response to IFN; ABL1, BCL2, BCR, FOXO3, IL18, PARP1, PRKDC, RUNX1, RUVBL1,
SAMHD1, SP1, STAT3, TERT, TP53, TREX1... Duplicated GGAA (TTCC) motifs are found
in number of the 5’-upstream regions of the human Interferon Stimulated genes (ISGs)
[61]. The observation suggests that expression of some of the DNA repair factor-encoding
genes might be up-regulated by IFN-induced signals.
3.2. The GGAA (TTCC) motifs are often present in the 5’-flanking regions of the genes that
encode protein modification factors
PARP enzymes and p53, which have multiple functions in DNA repair process, are thought
to affect mitochondrial metabolism [29, 83]. We previously reported that 5’-upstream regions
of many of the mitochondrial function associated genes contain duplicated GGAA (TTCC)
motifs [12]. Therefore, mitochondrial function could be up-regulated when cells encounter
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with various stresses, including DNA damage, viral infections, or tumorigenesis. It is note‐
worthy that PARP enzymes consume NAD+ to synthesize poly(ADP-ribose)s on various target
proteins, including p53 [18, 19]. Given that NAD+ is an essential molecule for energy metabo‐
lism, the ratio of inner cellular NAD+/NADH may keep balance of mitochondria/DNA repair
system. SIRT1, which is known as a NAD+ dependent de-acetylating enzyme, is not only
involved in controlling life spans of organisms but also DNA repair system with PARPs [84].
Besides affecting transcription by its de-acetylating activity, SIRT1 may indirectly contribute
to regulate inner cellular acetyl-CoA level [85]. SIRT3, which localizes in mitochondria,
catalyzes de-acetylation of acyl-CoA dehydrogenase and acetyl CoA synthase 2 [86-88]. It
should be noted that SIRT3 gene is head-head configured with PSMD13 gene [89], and that
the bidirectional promoter contains a sequence, 5’-ACTAGGGAACTTCCTCTAC-3’ [12]. It is
important to remind that both the NAD+ and the acetyl-CoA are essential molecules in energy
metabolism. Thus, GGAA-mediated transcription might be a biologically constitutional
response to nutrition stress.
Not only the ubiquitin encoding genes, UBB and UBC, ubiquitin metabolism factor encoding
genes, including UBE2B, UBE2T, UBE2V1, UBE2V2, UBE2W, UBR5, UHRF1, USP1, USP3,
USP28, and USP47, are included in Table 1. Protein ubiquitination has been suggested to
regulate DNA repair [90]. Notably, SUMOylation, which is a modification of proteins with
Small Ubiquitin-like Modifier [91], plays an important role in DNA repair [92, 93]. The
duplicated GGAA motif is also present in the SUMO1 promoter [50]. Furthermore, UBA1,
whose encoding gene is listed in Table 1, is a SUMO1 activating enzyme [94].
3.3. Possible roles of the duplicated GGAA motif in the 5’-upstream regions of DNA-repair
genes
Genome wide analysis of the human promoters revealed that c-ETS binding element is
frequently found with another c-ETS binding element [95, 96]. Redundant occupation of the
duplicated GGAA motifs by Ets family proteins seems to be a complicated system, but this
would enable finely tuned regulation of each promoter through altering composition of Ets
family or GGAA-binding proteins, including GABP and STATs, in the nucleus in response to
cellular signals [95].
4. Bidirectional promoters that regulate DNA repair factor-encoding genes
From the surveillance of the human DNA data base, not only mitochondrial function associ‐
ated genes but also DNA repair factor encoding genes have head-head oriented partner genes
[12]. Recent studies on RNA sequencing revealed a wide variety of transcripts, and the human
DNA data base is continuously updated. Therefore, numbers of known bidirectional promot‐
ers are increasing day by day. As the reason why so many genes have bidirectional partners
has not yet been elucidated, there is great value in investigating the role of bidirectional
promoters driving transcription of DNA-repair factor encoding genes.
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4.1. Surveillance of the bidirectional promoters from human genomic database
We have reported that a lot of human mitochondrial function associated genes have a
bidirectional partner [12]. Moreover, several DNA repair associated genes are head-head
configured with another gene [11]. Re-surveillance of DNA repair factor-encoding genes
revealed that a number of the genes have opposite direction transcribed partner genes,
utilizing the same regulatory region as their common promoter (Table 1). Although the number
of the bidirectional gene pair is increasing according to recent findings of transcripts with next
generation sequencing, at least 95 gene pairs were identified from the surveillance of the 358
DNA repair associated genes whose promoter contains GGAA (TTCC) motifs. The observation
suggests that duplicated GGAA (TTCC) motifs and the binding factors may play a part in the
bidirectional transcription of both mitochondrial function- and DNA repair-associated genes.
However, these genes are not always simply controlled by GGAA-motif alone. For example,
Sp1 binding element or GC-box is co-localized with ETS binding motifs in human promoters
with 28.4% occurrence [95]. Co-operation of the GABP binding motif with Sp1/3 and YY1
binding sites is required for murine Gabpa-Atp5j bidirectional promoter [97]. These observa‐
tions suggest that another cis-element, such as GC-box, may play a role in the co-operative
transcription.
4.2. Biological relevance of bidirectional transcription
It has been reported that many cancer or DNA repair associated genes have bidirectional
partner genes, and that tandem repeated ETS binding sites are frequently found in the 5’-
upstream regions of both genes [98-101]. Therefore, expression of many DNA repair factor
encoding genes is thought to be regulated by TFs that bind to GGAA motifs.
Surveillance of the human genomic sequence database revealed that several ISGs have
bidirectional partner genes [61]. Similar to the bidirectional promoters involved with DNA
repair factor encoding genes, bidirectional ISG promoters contain duplicated GGAA motifs.
They are BAG1-CHMP5, BLZF1-NME7, EIF3L-ANKRP54, CCDC75-HEART5B, IFI27L1-
DDX24, PARP10-PLEC, PSMA2-MRPL32, RPL22-RNF207, and TRADD-FBXL8 [61]. It is
noteworthy that the bidirectional gene pair HSPD1-HSPE1, which encodes the mitochondrial
chaperon proteins HSP60 and HSP10, respectively, has been reported to be regulated by IFN
gamma [102]. These findings suggest that promoters of the DNA-repair and mitochondrial
function associated genes that carry duplicated GGAA-motifs could be simultaneously
regulated by IFN-induced signals.
5. Cellular senescence and cancer generation might be simultaneously
regulated at transcriptional level
Introduction of several transcription factors (OSKM or Yamanaka factors) into somatic cells
could reprogram and generate induced pluripotent stem (iPS) cells [103]. Recently, it was
demonstrated that three transcription factors, Blimp1, Prdm14, and Tfap2c, direct epiblast-like
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cells into primordial germ cells [104]. Moreover, transcription factor C/EBPα enhances effects
of the OSKM factors to reprogram B cells [105]. These lines of evidences imply that the
transcriptional profile determines cell fate towards proliferation, cell cycle arrest, differentia‐
tion, senescence or programmed cell death. Furthermore, it has been postulated that nutrient
or metabolite state may contribute to affecting the balance between quiescence and prolifera‐
tion of stem cells [106]. In this article, we would propose a hypothesis that DNA-repair and
mitochondrial functions are regulated by the same or similar mechanisms that affect tran‐
scription of various genes via common duplicated GGAA motifs. The scenario is that tran‐
scriptional dysregulation should proceed to characteristics of cancer, including mitochondrial
dysfunction and genomic instabilities. Conversely, cancer and malignant tumors could be
reprogrammed to benign state if transcriptional state in the cells were altered.
5.1. Effect of caloric restriction (CR) mimetic drugs on telomere associated protein-encoding
gene promoters
Loss of function mutations on the WRN gene, which encodes telomere regulating RecQ
helicase, can lead to cancer or premature aging syndrome [107, 108]. On the other hand, caloric
restriction (CR) can extend life spans of various organisms [109], and thus CR mimetic drugs
may have an anti-aging effect. We therefore hypothesized that CR mimetic drugs activates
transcription of telomere-associated genes and demonstrated that promoter activities of the
human shelterin encoding genes are up-regulated by 2-deoxy-D-glucose (2DG) and Resvera‐
trol (Rsv) in HeLa S3 cells [110].
2DG and Rsv, which are known as a potent inhibitors of glucose metabolism [109], and an
activator of sirtuin-mediated de-acetylation [111], respectively, are often referred as CR
mimetic drugs. We observed moderate activation of telomerase activity in HeLa S3 cells with
2DG and Rsv treatment [110, 112], suggesting that CR mimetic drugs have protective effects
on telomeres by inducing telomerase activity along with up-regulating expression of the
telomere maintenance factor-encoding genes. The human TERT (hTERT) promoter has been
well characterized with c-Ets, GC-box, E-box and other TF-binding elements that are located
in its 5’-flanking region [113, 114]. GC-boxes and Sp1-binding sites are frequently found in the
human TERT, WRN and shelterin protein-encoding gene promoters with duplicated GGAA
elements that present adjacent to TSSs [110, 115].
Interestingly, both duplicated GGAA-motif and GC-boxes are contained within 500-bp
upstream of the TSS of the human SIRT1 gene [116]. SIRT1, which plays a role in NAD+
dependent de-acetylation of various proteins including histones, PGC-1α, FOXO1, p53 and
HIF1α, is proposed to regulate aging and the healthspan of organisms [117]. Human SIRT1
gene expression is regulated by PPARβ/γ through Sp1 binding elements [118]. Therefore,
signals evoked by CR or CR mimetic drugs might induce Sp1 or GC-box binding TFs, thus
simultaneously up-regulating expression of TERT, WRN, SIRT1, and the shelterin-encoding
genes. Given that the CR imposes a stress on cells due to the lack of nutrients or energy to
survive, cells need to stop growth but need to keep the integrity of chromosomes and telomeres
without replication of their genome. Under these circumstances, cells may require full
commitment of mitochondria to drive TCA cycle and OXPHOS generating more ATP mole‐
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cules than glycolysis does. Therefore, CR mimetic compounds with ability to induce telomere
maintenance factor encoding genes might be anti-aging drugs simultaneously up-regulating
expression of mitochondrial function associated genes.
5.2. Mechanisms that regulate aging or lifespan via mitochondria and metabolic state
Genetic studies of C. elegans implied that the insulin/IGF-1 signaling pathway regulates the
lifespan of animals [119]. Insulin/IGF-1 signaling and glucose metabolism are thought to be
associated with several diabetes/obesity controlling factors, including AKT, FOXO, mTOR and
AMPK [120]. The mTOR is a component of mTORC1 and mTORC2 that play key roles in signal
transduction in response to changes in energy balance [120]. Recently, it was reported that
mTORC1 in the Paneth cell niche plays a role in calorie intake by modulating cADPR release
from cells [121]. AMPK is known to be a sensor for energy stress and DNA damage to induce
phosphorylation of various TFs, such as FOXO, PGC-1α, CREB and HDAC5 [120, 122].
Moreover, AMPK regulates SIRT1 activity by modulating NAD+ metabolism [122].
Mitochondrial functions are known to affect lifespan of organisms [123]. Furthermore, a cross
talk between telomeres and mitochondria is suggested to regulate aging [124]. This concept
was implied from a Tert knock down experiment that indicates telomere dysfunction causes
suppression of PGC-1α in a p53-mediated manner [6]. The tumor suppressor p53 has been
suggested to affect aging of organisms as a pro-aging factor [125]. It does not only affect cell
cycle arrest and apoptosis, but also play a role in mitochondrial respiration and glycolysis [126,
127]. These lines of evidences strongly suggest that p53-mediated signaling is transferred to
both telomeres and mitochondria to control cellular senescence. Although no canonical GC-
boxes are found, duplicated GGAA-motifs are located near the TSS of the human TP53
promoter (Table 1). Detailed analysis of the TP53-WRAP53 bidirectional promoter region
revealed that both the duplicated GGAA motif and a putative E2F binding sequence are
involved in the response to Rsv [128]. Therefore, various stresses from DNA damage, viral
infection, or lack of nutrients, will activate expression of genes encoding DNA repair/mito‐
chondrial/telomere maintenance-associated factors via duplicated GGAA-motif with help
from other cis-elements, including GC-box and E2F elements.
5.3. Implication of transcriptional control on genes that encode TCA cycle enzymes
It has long been argued how and why cancers are generated. Recently, diagnosis of cancer and
diseases that are thought to occur from genomic alterations could be analyzed by second-
generation sequencing [129]. In general, it has been thought that cancer is a genetic disease
with several mutations on driver genes, including PIK3CA, IDH1 and RB1 [130]. Another
aspect of cancer is that it is a metabolic disease [79]. It is widely known that cancer consumes
more glucose to produce ATP by glycolysis or fermentation. The metabolic state of the cells
could be referred to as the “Warburg effect” [131]. Importantly, TCA-cycle enzymes, FH
(Fumarate hydratase) and SDH (succinate dehydrogenage) have been suggested as tumor
suppressors [132]. We have confirmed that duplicated GGAA motifs are present near TSSs of
the CS, ACO2, IDH1, IDH3A, IDH3B, SUCLG1, SDHAF2, SDHB, SDHD, FH, and ACLY genes
that encode enzymes in the TCA-cycle [12]. In this chapter, it was shown that a number of the
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5’-upstream regions of DNA repair factor- and IFN responding factor-encoding genes contain
duplicated GGAA (TTCC) motifs near their TSSs. The observation suggests that expression of
genes encoding TCA cycle enzymes is mediated by GGAA-motifs in a similar manner to that
of DNA repair factor encoding genes.
 
 
 
Figure 1. Dysfunction of tricarboxylic acid (TCA) cycle, which could be caused by alteration of GGAA-dependent tran‐
scription, may enforce the “Warburg effect”. Duplicated GGAA-motifs are contained in the 5’-upstream regions of the
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ACO2, GLUD2, IDH1, IDH3A, IDH3B, MDH2, ME2, SUCLG1, SDHAF2/SDHB/SDHD, FH, ACLY, CS, and PDHX genes
(red). The activity of the IDH3 complex, OGDH, and MDH1B will be reduced when NAD+/NADH ratio was attenuat‐
ed according to the poly(ADP-ribosyl)ation when cells encountered DNA-damage. Compounds highlighted in yellow
indicate metabolites that are produced when dysfunction of mitochondria and PARP activation has occurred, which
push the cycle in the counter clockwise direction (reductive carboxylation). When FH and SDHs do not work suffi‐
ciently, glutamate will be used as a source to process TCA-cycle. Various cellular stresses, including chemicals, X-ray
and UV irradiation, virus infection, and aging, may alter the quality and/or quantity profile of the GGAA-binding fac‐
tors in a normal cell (upper panel). That will lead to disruption of the mitochondrial- and DNA repair function-associ‐
ated gene expression. Repeated DNA-damage will enforce PARP activity to consume and deplete NAD+ molecule
from cytoplasm and mitochondria. When NAD+/NADH ratio decreased to cause dysfunction of the TCA-cycle, cells
would synthesize ATP by glycolysis or fermentation (lower panel). The consequence could be referred to as the “War‐
burg effect”.
5.4. Regulation of rate limitting factors in the DNA repair system
As noted in 3.2., PARP, which localizes in mitochondria, may play a key role as one of the rate
limitting factors in the DNA repair system. Poly(ADP-ribosyl)ation is essential for DNA repair,
especially in cells that have deficiencies in BRCA, which is also known to localize in mito‐
chondria [78, 79]. Therefore, highly potent inhibitors for PARP1 have been tested in different
clinical trials [47]. Inhibition of the PARP enzyme will not only prevent over consumption of
the NAD+ molecule, but it also blocks DNA repair systems in cancer cells. This balance in
metabolism/DNA repair should be taken into account for treatment of cancer patients. The
other key factor in mitochondria is the p53, which is frequently referred as a “gurdian of the
genome“ [27, 28]. Although it has not been elucidated which TFs play essential roles in the
regulation of those rate limitting factors in DNA repair, cells have some systems to monitor
metabolites. For instance, C terminal-binding protein (CtBP), which is a transcriptional
repressor of tumor suppressors [133], regulates BRCA1 gene expression in a NAD+/NADH
ratio-dependent manner [134]. This implies that a metabolic swich mediated by CtBP plays a
role in the regulation of the genes encoding DNA repair factors.
5.5. Alteration in transcriptional profile may cause cancerous state
It has been postulated that epigenetic and/or transcriptional changes play a role to determine
chromatin states in tumor cells [135]. Recent genomic studies indicated alterations of gene
expression in many human diseases [136, 137]. The transcriptome indicating cis- quantitative
trait loci (QTLs) has been reported as value to reveal gene expression and transcription state
in cells from patients of specific disease [138]. Cancer incidence in humans increase exponen‐
tially with age, suggesting that aging is the strongest demographic risk factor for most human
malignancies [139, 140]. This has been mainly explained by reactive oxygen species (ROS)
generation and accumulation of DNA damage on chromosomes or increased genomic stability,
including telomere shortening [140]. Moreover, hypoxia, which will attenuate DNA damage
response causing an increased mutation rate and chromosomal instability, has been suggested
to modulate senescence [141, 142]. Importantly, aging is accompanied with epigenetic change
and alteration of gene expression profile [143, 144]. Numerous GGAA motif-binding TFs acting
as positive and negative transcriptional regulators, could drive mitochondrial- and DNA
repair factor-encoding genes. The redundancy of the binding factors to the related sequences
may help to control expression of a specific gene with accuracy, and subtle changes in the
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profile of the TFs would not cause severe abnormalities in normal cells. However, repeated
cell division and extracellular signals will gradually disturb the balance of TFs that bind to
GGAA (TTCC) motifs, and finally lead to dysregulation of mitochondrial functions, DNA-
repair system, and IFN-response simultaneously. At this stage, abnormalities in metabolism,
mutations on DNAs, and aberrant IFN response would be observed in the cells. These features
could be referred to as characteristics of cancer and malignant tumors. Moreover, DNA
damage-inducing signals will activate poly(ADP-ribosyl)ation to lead to over consumption of
NAD+ molecule for poly (ADP-ribose) synthesis. The reduction of NAD+/NADH ratio in
mitochondria may in turn reverse the direction of the TCA cycle. If the TCA cycle cannot meet
demand for ATP levels, cells will abandon dependence on the normal respiratory system in
favour of up-regulating glycolysis or fermentation (Fig. 1).
6. Concluding remarks
It remains unclear how the GGAA motif has been duplicated and incorporated into specific
regulatory regions of various genes. However, the duplication of TF binding site might have
been advantageous for organisms in the course of evolution. The crystal structure of mouse
Elf3 with type II TGF-β receptor promoter was reported [145], representing an association
model of the ets motif binding protein with the duplicated GGAA motifs. Very recently, it was
shown that binding sites for MYC and its partner MIZ correlate with Pol II binding and
transcription start site [146], implying that two adjacent TF-binding sites play significant roles
in the regulation of transcription of multiple genes. At least twenty seven ETS family proteins
and other TFs, including GABP, NF-κB/c-Rel, and STAT proteins, recognize the sequence.
Therefore, the transcriptional efficiency could be determined only by the distance between
GGAA (TTCC) sequences, variation of the flanking sequences and the combination of binding
factors, which might have acquired variations as a consequence of evolution.
It has been shown that a lot of head-head configured gene pairs are contained in human
genomes [99]. In this chapter, we proposed a mechanism that alterations in the transcriptional
state in the cells lead to insufficient mitochondrial function accompanied with impaired DNA
repair system. In this regard, cancer could be referred to as a “transcriptional disease“. Given
that introduction of the four OSKM (Yamanaka) factors enables reprogramming of cell,
enforced expression of some TFs could reprogramm metabolic state in cancerous cells [103].
In order to assess the possibility, elucidation of how human genes, especially those that encode
mitochondrial function- and DNA repair-associated factors, are regulated by GGAA motif-
dependent transcription system, should be done [128]. If the mechanism were revealed,
scientists could establish gene therapy to let pre-cancerous cells regain normal TCA cycle/
respiration from unhealthy ATP-synthesis, or get rid of “Warburg effect”. In addition, this
therapy will up-regulate DNA repair system. We believe that the concept is valuable, though
not yet fully cultivated, to find a way to next generation cancer treatment with much lower
side effects.
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